https://www.selleckchem.com/pr....oducts/-r-s--3-5-dhp
Stereotactic body radiation therapy (SBRT) is increasingly used for patients with recurrent and or metastatic tumors. Sarcomas are generally considered not sensitive to radiotherapy and SBRT may allow for increased biological effectiveness. We report intermediate outcomes and toxicity for pediatric, adolescent, and young adult patients treated with SBRT to sites of recurrent and or metastatic sarcoma. We queried an Institutional Review Board-approved registry of patients treated with SBRT for metastases from pediatric sarcomas. P
Like
Comment
Share
